LIN52 and DYRK1A

Number of citations of the paper that reports this interaction (PubMedID 21498571)
54

Data Source:
BioGRID (enzymatic study, enzymatic study, enzymatic study)

		LIN52	DYRK1A
Description		lin-52 DREAM MuvB core complex component	dual specificity tyrosine phosphorylation regulated kinase 1A
Image
GO Annotations	Cellular Component	Nucleoplasm DRM Complex	Nucleus Nucleoplasm Cytoplasm Cytoskeleton Nuclear Speck Axon Dendrite Ribonucleoprotein Complex
	Molecular Function		Transcription Coactivator Activity Protein Kinase Activity Protein Serine/threonine Kinase Activity Protein Serine/threonine/tyrosine Kinase Activity Protein Tyrosine Kinase Activity Non-membrane Spanning Protein Tyrosine Kinase Activity Protein Binding ATP Binding Identical Protein Binding Protein Self-association Tau Protein Binding Tau-protein Kinase Activity
	Biological Process	Transcription, DNA-templated Regulation Of Cell Cycle	Regulation Of Alternative MRNA Splicing, Via Spliceosome Protein Phosphorylation Nervous System Development Circadian Rhythm Viral Process Peptidyl-serine Phosphorylation Peptidyl-threonine Phosphorylation Peptidyl-tyrosine Phosphorylation Negative Regulation Of Microtubule Polymerization Positive Regulation Of RNA Splicing Amyloid-beta Formation Peptidyl-serine Autophosphorylation Peptidyl-tyrosine Autophosphorylation Negative Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator Positive Regulation Of Transcription, DNA-templated Protein Autophosphorylation Negative Regulation Of MRNA Splicing, Via Spliceosome Positive Regulation Of Protein Deacetylation
Pathways		Transcription of E2F targets under negative control by DREAM complex Transcription of E2F targets under negative control by DREAM complex Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 G0 and Early G1 Polo-like kinase mediated events Cyclin E associated events during G1/S transition G1/S-Specific Transcription Cyclin A:Cdk2-associated events at S phase entry	G0 and Early G1
Drugs			N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
Diseases
GWAS		Blood protein levels ( 28240269) Chronotype ( 30696823) Macular thickness ( 30535121) Waist-hip ratio ( 28552196)	HIV-1 replication ( 21364930) Metabolic syndrome ( 20694148) Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892) Stroke ( 30383316)
Interacting Genes		5 interacting genes: DYRK1A MYBL2 NEK9 RBBP4 RBL2	31 interacting genes: - AMPH APP CCNL2 CLASRP CREB1 EIF2B5 FOXO1 GLI1 H2BC3 H3C1 H4C1 ID2 LATS2 LIN52 MAPT PEA15 PHYHIP PRKN RB1 RBL1 RNF169 SF3B1 SNCA SRSF1 SRSF4 SRSF5 TROAP YWHAB YWHAE YWHAG
Entrez ID		91750	1859
HPRD ID		18708	09018
Ensembl ID		ENSG00000205659	ENSG00000157540
Uniprot IDs		B3KN83 Q52LA3	A0A2R8Y6I6 Q13627
PDB IDs		4YOO 6C48	2VX3 2WO6 3ANQ 3ANR 4AZE 4MQ1 4MQ2 4NCT 4YLJ 4YLK 4YLL 4YU2 5A3X 5A4E 5A4L 5A4Q 5A4T 5A54 5AIK 6A1F 6A1G 6EIF 6EIJ 6EIL 6EIP 6EIQ 6EIR 6EIS 6EIV 6EJ4 6S11 6S14 6S17 6S1B 6S1H 6S1I 6S1J
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?